DOCSLIB.ORG

Contribution of the Pitié-Salpêtrière Hospital to French Anesthesiology

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Contribution of the Pitié-Salpêtrière Hospital to French Anesthesiology EDITORIAL VIEWS ALN Editorial Views Contribution of the Pitié-Salpêtrière Hospital to French Editorial Views Anesthesiology 6 Editorial Note: This issue includes 13 articles and 3 Editorials from or about work from the Department of Anesthesiol- ogy and Critical Care in Pitié-Salpêtrière in Paris, which celebrated its 400-yr anniversary this year. All articles underwent rigorous peer review with no special consideration and we are pleased to highlight the recent and past contributions of this outstanding department and institution. Downloaded from http://pubs.asahq.org/anesthesiology/article-pdf/117/6/1147/258772/0000542-201212000-00005.pdf by guest on 30 September 2021 10.1097/ALN.0b013e31827558af December HE Pitié-Salpêtrière hospital, Working in a hospital that is T founded in 1612 as a home celebrating its 400th anniversary for the poor and then as a hospice, implies constantly projecting has been progressively transformed medical practice into the future. In over the years to become a center France, the anesthesiology–critical of excellence in the field of health care specialty, driven by the impetus (fig. 1) The 2,000 conventional hos- provided by Pierre Viars, M.D. pital beds have been decreased to (Professor, University Pierre et Marie allow the construction of modern Curie, Paris, France (1930–1998), technical units, which have allowed head of the Pitié-Salpêtrière hospital both the development of major sur- “In France, the anesthesi- Department of Anesthesiology gery and the management of out- and Critical Care from 1972 to patient surgery patients. Today, the ology-critical care special- 1995, has largely contributed to Pitié-Salpêtrière hospital is one of the modernization of both our Europe’s oldest, largest (1,500 beds, ty, driven by the impetus specialty and, as a consequence, to 47 operating rooms, and 140 surgi- provid ed by Pierre Viars, surgical care. Professor Pierre Viars cal and multidisciplinary critical care was the real founder of the Pitié- unit beds, including the 80 surgical M.D. … [and further devel- Salpêtrière hospital Department of and multidisciplinary critical care Anesthesiology and Critical Care, unit beds managed by the Depart- oped by Pierre Coriat, M.D.] by forming a team that enabled him ment of Anesthesiology and Critical has largely contributed to to ensure clinical care, teaching, Care) and best renowned hospitals and research in the fields of both with a long-standing affiliation with the mod ernization of both anesthesiology and critical care, as the University of Paris, now Univer- clearly illustrated by the numerous sity Pierre et Marie Curie-Paris 6. our spe cialty and, as a con- articles published in this issue The Pitié-Salpêtrière hospital’s repu- sequence, to surgical care.” concerning studies performed in the tation dates back to the middle of department that he founded. the 19th century with the discover- It is relatively simple to describe ies of Charcot. In the second half of the 20th century, the the past and predict the future, but it is much more diffi- hospital’s surgical activity, particularly major surgery and cult to be clear-sighted in everyday practice. This particular transplantations, developed with the support of the Depart- quality enabled Pierre Viars to make French anesthesiology– ment of Anesthesiology and Critical Care. It was at the Pitié- critical care a full-fledged medical specialty. Observing that Salpêtrière, that Christian Cabrol, in 1968, performed the anesthesiology was not considered to be a real medical spe- first successful heart transplantation in Europe, allowing the cialty, but rather a “necessary evil,” all his life’s work was development of very active research on the care of brain- devoted to recognition of our specialty by the hospital com- dead organ donors in our department.1 munity, based on the principle that anesthesiology–critical care physicians play a central role in surgical practice, and are Photo: Submitted by the author. therefore essential. When recruiting physicians, he therefore Accepted for publication September 14, 2012. The author is required a high level of medical and scientific training, as not supported by, nor maintains any financial interest in, any he was convinced that only constant reference to medical commercial activity that may be associated with the topic of this article. progress would enable them to be recognized and consid- Copyright © 2012, the American Society of Anesthesiologists, Inc. Lippincott ered by physicians of other specialties. He was the first to Williams & Wilkins. Anesthesiology 2012; 117:1147-50 understand that basic and clinical research was essential for Anesthesiology, V 117 • No 6 1147 December 2012 Editorial Views Downloaded from http://pubs.asahq.org/anesthesiology/article-pdf/117/6/1147/258772/0000542-201212000-00005.pdf by guest on 30 September 2021 Fig. 1. Image of the hospital at the 17th century (with permission of the assistance Publique Hopitaux de Paris). French anesthesiology to ensure recognition of our specialty our department presented more abstracts than any country by other medical specialties and to ensure a leading role in in the world, except for the United States. These first steps in medical progress. clinical research for our residents probably play a crucial role He clearly understood that medical progress in anesthesiol- in encouraging them to conduct research. ogy and critical care, as in any field of medicine, had to be Management of the department also ensures that physi- driven by science and research and that transfer of discoveries cians have sufficient time for clinical research, by providing in the fields of physiology or pharmacology to medical prac- them with a salary equivalent to that received by physicians tice would allow significant progress in the management of with a full-time clinical activity. high-risk patients requiring anesthesia, as well as critically ill In our department, analysis of postoperative outcome is patients. Basic cardiovascular physiology and molecular biology performed prospectively in all high-risk patients, particularly and description of the structure of ion channels that are critical those undergoing cardiac and vascular surgery. Studies pub- for central nervous system functions are just a few examples of lished in this issue on the harmful effects of β-blockers2 and on how basic science can be transposed to clinical practice. the relevance of intubation criteria3 demonstrate that the large Today, in the footsteps of Professor Viars, the department’s number of operated patients managed in our hospital allow philosophy is based on identifying residents interested in powerful statistical analyses addressing clinical questions. research and convincing them to select a topic before the end Pierre Viars was encouraged and helped by Bruno Riou, of their residency as the subject of their research work once M.D., Ph.D., to form an experimental research laboratory in they have been recruited as a young member of staff, regard- the Pierre et Marie Curie School of Medicine specialized in less of the clinical sector to which they are allocated. The best the pathophysiological mechanisms of our specialty. This lab- residents were encouraged to obtain a master’s degree and/ oratory has enabled a large number of anesthesiologists from or Ph.D. in experimental research in various fields related all over France to conduct experimental research in our field. to anesthesia, critical care, or pain. Our objective has been Over recent years, we have also asked young anesthesiologists clearly to ensure each resident presents at least one abstract at in our department to obtain international experience for at our national meeting, many of them present an abstract at an least 1 yr. The international cooperation that we have devel- international meeting, and a significant proportion of them oped with many centers (Charlottesville, Milwaukee, and San will be able to finally publish an article. Presentation at the Francisco in the United States, London and Oxford in the American Society of Anesthesiology meetings was consid- United Kingdom) is a further step designed to improve both ered to be a must before the creation of the European Society the level of our research and the appeal of our department. of Anesthesiology in 1992. I remember that, in 1988, at the Pierre Viars was also one of the first to understand that San Francisco American Society of Anesthesiology meeting, critical care medicine requires dedicated anesthesiologists Anesthesiology 2012; 117:1147-50 1148 Pierre Coriat EDITORIAL VIEWS specifically trained in critical care medicine, working full- The French law of 1994 therefore overcame the reticence time in the critical care unit and ensuring global manage- expressed by various hospital communities to enforce certain ment of the patient. rules ensuring better patient safety and confirming anesthe- The articles published in this issue of ANESTHESIOLOGY siology as a full-fledged medical specialty. show that our department has continued its basic research A survey of anesthesia-related mortality in France illus- and clinical research activities in both anesthesiology and crit- trates the active role played by French anesthesiology in the ical care, and that this research has been facilitated by progress field of patient safety.8 This very large-scale, nationwide study in other fields, such as pharmacology, cardiovascular and neu- confirmed a 10-fold decrease in anesthesia-related mortality rological pathophysiology, and biotechnological
Load more

Recommended publications
  • 2014 FP 1-78:4-Color Section
    FINAL PROGRAM 34th Annual Meeting and Scientific Sessions April 10 – 13, 2014 MANCHESTER GRAND HYATT SAN DIEGO International Society for Heart and Lung Transplantation Gilead is committed to expanding healthcare options for individuals living with cardiovascular and pulmonary diseases through innovative research, access, and education programs. © 2013 Gilead Sciences, Inc. All rights reserved. UNBP0009 March 2013 Gilead and the Gilead logo are trademarks of Gilead Sciences, Inc. INTERNATIONAL SOCIETY FOR HEART AND LUNG TRANSPLANTATION 34th ANNUAL MEETING and SCIENTIFIC SESSIONS April 10 – 13, 2014 TABLE OF CONTENTS About ISHLT 2 Board of Directors 4 Scientific Program Committee 6 Abstract Reviewers 8 Committees 17 Scientific Councils 25 Past Presidents 32 Daily Schedule Foldouts between 34-47 Award Recipients 35 Continuing Medical Education 46 Annual Meeting 49 Scientific Session Highlights Manchester Grand Hyatt Floor Plans 64 Annual Meeting 67 Schedule At a Glance Corporate Partners 78 Annual Meeting 79 Scientific Program and Schedule Exhibit Hall Floor Plan 278 List of Exhibitors 280 1 2 THE INTERNATIONAL SOCIETY FOR HEART AND LUNG TRANSPLANTATION (ISHLT) is a not-for-profit, multidisciplinary, professional organization dedicated to improving the care of patients with advanced heart or lung disease through transplantation, mechanical support and innovative therapies via research, educa- tion and advocacy. ISHLT was created in 1981 at a small gathering of The about 15 cardiologists and Purposes cardiac surgeons. Today we of the have over 2700 members from over 45 countries, rep- Society resenting over 15 different are: professional disciplines in- 1. To associate persons volved in the management interested in the fields of heart and treatment of end-stage and lung transplantation, end- heart and lung disease.
    [Show full text]
  • 2004 Final Program
    The International Society for Heart and Lung Transplantation (a forum that includes basic science, the failing heart, and advanced lung disease) Twenty-Fourth Annual Meeting and Scientific Sessions April 21 – 24, 2004 Convening at the Hilton San Francisco San Francisco, CA Final Program Board of Directors President Jon Kobashigawa, MD, Los Angeles, CA President-Elect Alec Patterson, MD, St. Louis, MO Past President Stephan Schueler, MD, Newcastle, United Kingdom Secretary/Treasurer Robert C. Bourge, MD, Birmingham, AL Directors Paul A. Corris, MB, FRCP, Newcastle, United Kingdom F. Jay Fricker, MD, Gainesville, FL Katherine Hoercher, RN, Cleveland, OH Luigi Martinelli, MD, Genova, Italy Keith McNeil, MD, FRACP, Brisbane, Australia Mandeep R. Mehra, MD, New Orleans, LA Soon J. Park, MD, San Francisco, CA Hermann Reichenspurner, MD, PhD, Hamburg, Germany Bruce Rosengard, MD, FRCS, FACS, Cambridge, United Kingdom Heather J. Ross, MD, Toronto, Canada Adriana Zeevi, PhD, Pittsburgh, PA JHLT Editor James K. Kirklin, MD, Birmingham, AL Heart and Lung Transplant Registry Medical Director Marshall I. Hertz, MD, Minneapolis, MN Mechanical Circulatory Support Device Database Medical Director Mario C. Deng, MD, New York, NY Staff Amanda W. Rowe Executive Director Phyllis Glenn Assistant Executive Director Director of Membership Services Lisa Edwards Director of Meetings LeeAnn Mills Director of Operations 14673 Midway Road, Suite 200 Addison, TX 75001 Phone: 972-490-9495 Fax: 972-490-9499 www.ishlt.org [email protected] PAST PRESIDENTS 1981-1982 Michael Hess, MD 1982-1984 Jack Copeland, MD 1984-1986 Terence English, FRCS 1986-1988 Stuart Jamieson, MD 1988-1990 Bruno Reichart, MD 1990-1991 Margaret Billingham, MD 1991-1992 Christian Cabrol, MD 1992-1993 John O’Connell, MD 1993-1994 Eric Rose, MD 1994-1995 John Wallwork, FRCS 1995-1996 Sharon Hunt, MD 1996-1997 William Baumgartner, MD 1997-1998 Leslie Miller, MD 1998-1999 Alan Menkis, MD, FRCS(C) 1999-2000 Robert L.
    [Show full text]
  • Cardiac Surgeon, University Professor, and Politician Revista Argentina De Cardiología, Vol
    Revista Argentina de Cardiología ISSN: 0034-7000 [email protected] Sociedad Argentina de Cardiología Argentina Herreros, Jesús Christian Cabrol: Cardiac Surgeon, University Professor, and Politician Revista Argentina de Cardiología, vol. 85, núm. 3, junio, 2017, pp. 264-265 Sociedad Argentina de Cardiología Buenos Aires, Argentina Available in: http://www.redalyc.org/articulo.oa?id=305353231019 How to cite Complete issue Scientific Information System More information about this article Network of Scientific Journals from Latin America, the Caribbean, Spain and Portugal Journal's homepage in redalyc.org Non-profit academic project, developed under the open access initiative IN MEMORIAM Christian Cabrol: Cardiac Surgeon, University Professor, and Politician Christian Emile Cabrol, pioneer of cardiac, cardio- During the Journey across the Dessert, which took pulmonary, and artificial heart transplantation in place from 1969 to 1978, only four hospitals sus- Europe, passed away at the age of 91 in the early tained the program: Stanford University, the Groote morning of June 16, 2017, in the hospital to which he Schuur Hospital of South Africa, the Hôpital Pitié- dedicated his professional life. Salpêtrière, and the University of Richmond in Vir- He was born on September 16, 1925, in Chezy- ginia. These four centers managed to keep the fire sur-Marne, Aisne. He studied Medicine at the School burning and made it possible to renew the interest of Medicine in Paris. In 1949 Cabrol was resident in in transplantation, coinciding with the discovery of the Hospitals of Paris, and in 1951, he joined the De- the immunosuppressive properties of cyclosporine A. partment of Surgery of Professor Gaston Cordier, a Christian Cabrol also performed the first heart-lung visionary leader that encouraged him to become in- transplantation in Europe, on March 9, 1982, the terested in cardiopulmonary surgery.
    [Show full text]
  • History of Heart Transplantation: a Hard and Glorious Journey
    SPECIAL ARTICLE - HISTORIC Braz J Cardiovasc Surg 2017;32(5):423-7 History of Heart Transplantation: a Hard and Glorious Journey Noedir A. G. Stolf1, MD, PhD DOI: 10.21470/1678-9741-2017-0508 INTRODUCTION contractions were seen. Afterward contractions appeared and about an hour after the operation, effective contractions of This year we celebrate 50 years of the first interhuman heart the ventricles began. The transplanted heart beat at the rate of transplantation. So, I believe that it is interesting to review the 88 per minute, while the rate of the normal heart was 100 per most important steps of this glorious journey. minute. A little later tracing was taken. Owing to the fact that Heart transplantation first performed in the course of the operation was made without aseptic technique, coagulation experiments of other nature in the beginning of 20th century, occurred in the cavities of the heart after about two hours, and seen as a speculation for the future in the middle of the same the experiment was interrupted”. century, is now widely accepted by medical and lay communities Although the exact details of experiments were not known as a valuable therapeutic procedure. the most probable arrangement of anastomosis are shown in This history can be divided into an experimental and a Figure 1 adaptation in a book by Najarian and Simmons[2]. The clinical heart transplantation periods, with the first one in problem with this model is that arterial inflow is in the atrium heterotopic non-auxiliary, heterotopic auxiliary and orthotopic and aortic outflow is under venous pressure, in other words, transplantations.
    [Show full text]
  • Preliminary Program
    INTERNATIONAL SOCIETY FOR HEART AND LUNG TRANSPLANTATION Twenty-Second Annual Meeting and Scientific Sessions Final Program April 10-13, 2002 Convening at the Hilton Washington and Towers, Washington, DC PRESIDENT James B. Young, MD, Cleveland, OH PRESIDENT-ELECT Stephan Schueler, MD, Newcastle Upon Tyne, United Kingdom PAST PRESIDENT Anne Keogh, MBBS, MD, Sydney, Australia SECRETARY/TREASURER Alec Patterson, MD, St. Louis, MO DIRECTORS Robert C. Bourge, MD, Birmingham, AL Paul A. Corris, MB, FRCP, Newcastle Upon Tyne, United Kingdom F. Jay Fricker, MD, Gainesville, FL Axel Haverich, MD, Hannover, Germany Luigi Martinelli, MD, Genova, Italy Mehmet C. Oz, MD, New York, NY Sabina M. De Geest, RN, PhD, Basel, Switzerland W. Steves Ring, MD, Dallas, TX Robert C. Robbins, MD, Stanford, CA David O. Taylor, MD, Cleveland, OH Adriana Zeevi, PhD, Pittsburgh, PA JHLT EDITOR James K. Kirklin, MD, Birmingham, AL HEART AND LUNG TRANSPLANT REGISTRY MEDICAL DIRECTOR Marshall I. Hertz, MD, Minneapolis, MN MECHANICAL CIRCULATORY SUPPORT DEVICE DATABASE MEDICAL DIRECTOR Mario Deng, MD, New York, NY STAFF Amanda W. Rowe, Executive Director Phyllis Glenn, Director of Membership Services Lisa Edwards, Director of Meetings LeeAnn Mills, Director of Operations 14673 Midway Road, Suite 200 Addison, TX 75001 Phone: 972-490-9495 Fax: 972-490-9499 www.ishlt.org [email protected] INTERNATIONAL SOCIETY FOR HEART AND LUNG TRANSPLANTATION PAST PRESIDENTS 1981-1982 Michael Hess, MD 1982-1984 Jack Copeland, MD 1984-1986 Terence English, FRCS 1986-1988 Stuart Jamieson, MD 1988-1990 Bruno Reichart, MD 1990-1991 Margaret Billingham, MD 1991-1992 Christian Cabrol, MD 1992-1993 John O’Connell, MD 1993-1994 Eric Rose, MD 1994-1995 John Wallwork, FRCS 1995-1996 Sharon Hunt, MD 1996-1997 William Baumgartner, MD 1997-1998 Leslie Miller, MD 1998-1999 Alan Menkis, MD, FRCS(C) 1999-2000 Robert L.
    [Show full text]
  • How TV and Newspaper Coverage Furthered the Cause of Heart Transplantation in France (1968–1973)*
    Gesnerus 76/2 (2019) 279–307, DOI: 10.24894/Gesn-en.2019.76013 Surgical Emotions: How TV and Newspaper Coverage Furthered the Cause of Heart Transplantation in France (1968–1973)* Philippe Chavot, Anne Masseran Abstract This paper shows the infl uence of media coverage for the fate of heart trans- plantation in France. It argues that the media’s support not only reinforced the graft’s medical legitimacy, but also sustained the practice by mobilizing public support. Our study focuses on two peaks in media coverage. The fi rst took place in 1968/69, as the fi rst grafts in the world and in France were per- formed. The second occurred in 1973, when surgeries resumed in France fol- lowing a four-year hiatus due to the mixed results of the early operations. French transplants were then largely covered on TV and in newspapers. We examine the reasons for these peaks in coverage and the underlying ratio- nales of the alliance between French surgeons and journalists. Cross-analy- sis of TV and print productions sheds light on the media devices used to en- list the general public’s moral support. It shows that state television proved an effective platform for doctors, allowing for a different kind of storytelling than in newspapers. Television studies, science popularization, organ transplantation, France, heart transplant * This research received funding from the European Research Council (ERC) “The healthy self as body capital (BodyCapital)” project under the European Union’s Horizon 2020 re- search and innovation programme (grant agreement No 694817). We would like to thank the INA and its staff for making the archive descriptions and videos available to social sci- entists.
    [Show full text]
  • Comments on “Right Ventricular Failure in Septic Shock: Characterization, Incidence and Impact on Fluid Responsiveness”
    Abou‑Arab et al. Crit Care (2021) 25:136 https://doi.org/10.1186/s13054‑021‑03473‑0 LETTER Open Access Comments on “Right ventricular failure in septic shock: characterization, incidence and impact on fuid responsiveness”: which parameter to assess right ventricular failure and venous congestion? Osama Abou‑Arab1* , Mouhamed D. Moussa2, Christophe Beyls1 and Yazine Mahjoub1 To the editor echocardiography, the consensus defnition of the Ameri- We read with great interest the article by Veillard Baron can Society of Echocardiography and the European Asso- et al. about right ventricular (RV) failure in septic shock ciation of Cardiovascular Imaging of RV global systolic and its link with fuid responsiveness [1]. dysfunction is still based on RV-fractional area contrac- Te authors defned right ventricular failure as the tion (RV-FAC), whilst global RV function is based on association of RV dilatation (RV/LVEDA < 0.6) and right ventricular index of myocardial performance [2]. increased central venous pressure (CVP ≥ 8 mmHg). Tese parameters would have been of great interest in Tey showed that this defnition of RV failure is associ- this setting. ated with lack of fuid responsiveness. Terefore, CVP could be used as an additional measurement to RV dilata- Measurement of CVP tion to discriminate between patients with and without Several confusing factors could mislead in CVP interpre- congestive RV failure. Tis rationale seems attractive. tation in this context, especially because a large number However, several limitations may weaken the conclusion of patients in group 3 has a CVP between 8 and 10 mmHg of this study. and several patients of group 1 and 2 has a CVP close to 8 mmHg.
    [Show full text]
  • 2003 Final Program
    The International Society for Heart and Lung Transplantation Twenty-Third Annual Meeting and Scientific Sessions April 9-12, 2003 Convening at the Hofburg Congress Center Vienna, Austria Final Program Board of Directors President Stephan Schueler, MD, Newcastle, United Kingdom President-Elect Jon Kobashigawa, MD, Los Angeles, CA Past President James B. Young, MD, Cleveland, OH Secretary/Treasurer Alec Patterson, MD, St. Louis, MO Directors Paul A. Corris, MB, FRCP, Newcastle, United Kingdom Sabina M. De Geest, RN, PhD, Basel, Switzerland F. Jay Fricker, MD, Gainesville, FL Luigi Martinelli, MD, Genova, Italy Soon J. Park, MD, Minneapolis, MN Hermann Reichenspurner, MD, PhD, Hamburg, Germany W. Steves Ring, MD, Dallas, TX Robert C. Robbins, MD, Stanford, CA Heather J. Ross, MD, Toronto, Canada David O. Taylor, MD, Cleveland, OH Adriana Zeevi, PhD, Pittsburgh, PA JHLT Editor James K. Kirklin, MD, Birmingham, AL Heart and Lung Transplant Registry Medical Director Marshall I. Hertz, MD, Minneapolis, MN Mechanical Circulatory Support Device Database Medical Director Mario C. Deng, MD, New York, NY Staff Amanda W. Rowe Executive Director Phyllis Glenn Assistant Executive Director Director of Membership Services Lisa Edwards Director of Meetings LeeAnn Mills Director of Operations 14673 Midway Road, Suite 200 Addison, TX 75001 Phone: 972-490-9495 Fax: 972-490-9499 www.ishlt.org [email protected] PAST PRESIDENTS 1981-1982 Michael Hess, MD 1982-1984 Jack Copeland, MD 1984-1986 Terence English, FRCS 1986-1988 Stuart Jamieson, MD 1988-1990 Bruno Reichart, MD 1990-1991 Margaret Billingham, MD 1991-1992 Christian Cabrol, MD 1992-1993 John O’Connell, MD 1993-1994 Eric Rose, MD 1994-1995 John Wallwork, FRCS 1995-1996 Sharon Hunt, MD 1996-1997 William Baumgartner, MD 1997-1998 Leslie Miller, MD 1998-1999 Alan Menkis, MD, FRCS(C) 1999-2000 Robert L.
    [Show full text]
  • 4, No.-2, January 2012 Cardiovas Journal
    174 Vol.-4, No.-2, January 2012 Cardiovas Journal History of Cardiology War and the Development of Cardiac Surgery M Kamruzzaman1, F Amin2, SN Hosain3 1Combined Military Hospital, Dhaka.2 Department of Public health, Univ. KL Royal College of Medicine, Perak, Malaysia.3Department of cardiac surgery, Chittagong Medical College, Chittagong. Abstract Despite all the devastating effects, wars have made some very significant positive impact in the development of cardiac surgery. Heart is an organ that cannot be stopped even for a minute, there by making it very difficult for the surgeons to operate. The wars of the Twentieth Century, particularly the two Great wars produced a significant number of patients with heart injury to reach surgeons’ operating tables. This gave the surgeons a unique opportunity to study, operate, practice and research cardiac surgical patients. Notable names including Wilfred Bigelow, Walton Lillehei, John Gibbon, Christian Cabrol, Vasilii Kolessov and Alexander Vishnevsky all were world war veterans and utilized their wartime experience later on in the development of cardiac surgery. Had there not been the two great wars, the development of cardiac surgery would have been delayed probably by years. (Cardiovasc. j. 2012; 4(2): 174-178) Introduction: the circulation resulting in very serious embolc ‘War’ is the word hatred by the common people all problems in other organs. Moreover the position over the world. Again war has remained the of the heart secured by the chest cage makes ultimate method of settling disputes between the surgical approach very difficult. Considering all communities and nations since the time ancient. these facts, famous surgeon Stephen Paget1 in Despite all the devastating effect of this man made 1895 wrote, “Surgery of the heart has probably disaster, war remains a reality as ever.
    [Show full text]
  • THE AMERICAN ASSOCIATION for THORACIC SURGERY 1989 -1990 President F
    1990 ANNUAL MEETING PROGRAM Back to all Annual Meeting Programs Committees Monday Morning Monday Afternoon Tuesday Morning Tuesday Afternoon Wednesday Morning Wednesday Afternoon Geographical Roster Bylaws Meetings Dates Presidents of AATS Awards COMMITTEES Back to Annual Meeting Program THE AMERICAN ASSOCIATION FOR THORACIC SURGERY 1989 -1990 President F. Griffith Pearson, Toronto, Ontario, Canada Vice-President Keith Reemtsma, New York, NY Secretary Martin F. McKneally, Albany, NY Treasurer William A. Gay, Jr., Salt Lake City, UT Editor John W. Kirklin, Birmingham, AL Councillors W. Gerald Austen, (1990), Boston, MA L. Henry Edmunds, Jr. (1992), Philadelphia, PA Tom R. Demeester (1993), Omaha, NE Nicholas T. Kouchoukos (1991), St. Louis, MO John A. Waldhausen (1990), Hershey, PA Membership Committee Randall B. Griepp, Chairman, New York, NY Delos M. Cosgrove, Cleveland, OH James K. Kirklin, Birmingham, AL Alex G. Little, Las Vegas, NV Ashby C. Moncure, Boston, MA Kevin Turley, San Francisco, CA William G. Williams, Toronto, Ontario, Canada Association Representatives, Nicholas T. Kouchoukos, St. Louis, MO The American Board of James V. Maloney, Jr., Los Angeles, CA Thoracic Surgery John A. Waldhausen, Hershey, PA Board of Governors, Anthony R.C. Dobell (1990), Montreal, Quebec, Canada American College of Surgeons Robert B. Wallace (1991), Washington, DC THE AMERICAN ASSOCIATION FOR THORACIC SURGERY 1990 Annual Meeting COMMITTEES LOCAL ARRANGEMENTS Richard D. Weisel, Chairman Ronald J. Baird Tirone E. David Bernard S. Goldman Lynda L. Mickleborough Alexander G.Patterson F. Griffith Pearson Thomas A. Salerno Hugh E. Scully Thomas R.J. Todd George A. Trusler William G. Williams LADIES' HOSPITALITY COMMITTEE Charlene Weisel, Committee Chairwoman Fern Baird Jacqueline David Fran Goldman Vanessa Harwood Hilppa Raveala Michelle Salerno Connie Trusler Gail Williams AMERICAN ASSOCIATION FOR THORACIC SURGERY COMMITTEES 1989-1990 PROGRAM COMMITTEE Chairman, F.
    [Show full text]
  • Fiftieth Anniversary of the First Heart Transplantation in Switzerland in the Context of the Worldwide History of Heart Transplantation
    Zurich Open Repository and Archive University of Zurich Main Library Strickhofstrasse 39 CH-8057 Zurich www.zora.uzh.ch Year: 2020 Fiftieth anniversary of the first heart transplantation in Switzerland inthe context of the worldwide history of heart transplantation Wilhelm, Markus J ; Ruschitzka, Frank ; Flammer, Andreas J ; Bettex, Dominique ; Turina, Marko I ; Maisano, Francesco Abstract: On 3 December 1967, Christiaan Barnard performed the first heart transplantation in the world at Groote Schuur Hospital in Cape Town, South Africa. In the succeeding months, heart transplantations in the USA, Asia and Europe followed. On 14 April 1969, Aring;ke Senning successfully accomplished the first heart transplantation in Switzerland at the former Cantonal Hospital in Zurich. In the summerof 1969, he undertook a second heart transplantation. Although the surgical procedure went well technically, both patients died within weeks to months after transplantation. Causes of death were infection in the first and rejection in the second patient. Senningrsquo;s colleagues around the world hadsimilar experiences. Survival after heart transplantation was unacceptably low. The heart transplant community recognised the lack of knowledge about immunological processes and appropriate immunosuppressive regimens as underlying reason for the early deaths. Most transplant centres decided to refrain from heart transplantation until sufficient immunological insight became available. After the introduction of the new immunosuppressive drug ciclosporin into the clinic and the availability of tools to monitor rejection in the early 1980s, heart transplant programmes were restarted all over the world. The legal recognition of brain death allowed procurement of donor hearts without exposure to warm ischaemia, and the principle of cold storage enabled prolongation of ischaemia time and acceptance of donors in distant hospitals, resulting in enlargement of the donor pool.
    [Show full text]